Publikationen in Zusammenarbeit mit Forschern von Brigham and Women's Hospital (109)

2022

  1. Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects

    Drug Discovery Today, Vol. 27, Núm. 2, pp. 436-455

  2. Arginine catabolism metabolites and atrial fibrillation or heart failure risk: 2 case-control studies within the Prevención con Dieta Mediterránea (PREDIMED) trial

    The American journal of clinical nutrition, Vol. 116, Núm. 3, pp. 653-662

  3. Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers

    Parkinsonism and Related Disorders, Vol. 96, pp. 29-35

  4. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  5. Genomic profiling for clinical decision making in lymphoid neoplasms

    Blood

  6. Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction

    Arthritis Care and Research, Vol. 74, Núm. 10, pp. 1649-1658

  7. Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry

    ESC Heart Failure, Vol. 9, Núm. 4, pp. 2189-2198

  8. Plasma acylcarnitines and risk of incident heart failure and atrial fibrillation: the Prevención con dieta mediterránea study

    Revista Espanola de Cardiologia, Vol. 75, Núm. 8, pp. 649-658

  9. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature